Press Releases

Advanced Search
  • May 31, 2018

    Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, has elected Hong Yu as...

  • May 25, 2018

    Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today announced that Dr....

  • May 10, 2018
    - Steady progress in the new year signals strengthening financial and technology positions

    Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today announced its...

  • May 4, 2018
    - Conference Call with Live Audio Webcast on Thursday, May 10th at 9:00 AM ET -

    Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, announced today that it...

  • Apr 2, 2018
    - Fourth Quarter Headcount Reduction and Private Placement Extend Operational Runway

    Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and...

Show 5102550100 per page

print email rss